Risk factors for acquisition and loss of Clostridium difficile colonization in hospitalized patients

Erik R. Dubberke, Kimberly A. Reske, Sondra Seiler, Tiffany Hink, Jennie H. Kwon, Carey Ann D. Burnham

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Asymptomatic colonization may contribute to Clostridium difficile transmission. Few data identify which patients are at risk for colonization. We performed a prospective cohort study of C. difficile colonization and risk factors for C. difficile acquisition and loss in hospitalized patients. Patients admitted to medical or surgical wards at a tertiary care hospital were enrolled; interviews and chart review were performed to determine patient demographics, C. difficile infection (CDI) history, medications, and health care exposures. Stool samples/rectal swabs were collected at enrollment and discharge; stool samples from clinical laboratory tests were also included. Samples were cultured for C. difficile, and the isolates were tested for toxins A and B and ribotyped. Chi-square tests and univariate logistic regression were used for the analyses. Two hundred thirty-five patients were enrolled. Of the patients, 21% were colonized with C. difficile (toxigenic and nontoxigenic) at admission and 24% at discharge. Ribotype 027 accounted for 6% of the strains at admission and 12% at discharge. Of the patients colonized at admission, 78% were also colonized at discharge. Cephalosporin use was associated with C. difficile acquisition (47% of patients who acquired C. difficile versus 25% of patients who did not; P = 0.03). β-lactam-β-lactamase inhibitor combinations were associated with a loss of C. difficile colonization (36% of patients who lost C. difficile colonization versus 8% of patients colonized at both admission and discharge; P = 0.04), as was metronidazole (27% versus 3%; P = 0.03). Antibiotic use affects the epidemiology of asymptomatic C. difficile colonization, including acquisition and loss, and it requires additional study.

Original languageEnglish
Pages (from-to)4533-4543
Number of pages11
JournalAntimicrobial agents and chemotherapy
Volume59
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Dive into the research topics of 'Risk factors for acquisition and loss of Clostridium difficile colonization in hospitalized patients'. Together they form a unique fingerprint.

Cite this